Antonio Paul: When a Low Platelet Count Does Not Mean Weak Clotting
Antonio Paul, Head of ACTIMoS- Advanced Center for Transplant Immunology and Molecular Science, shared a post on LinkedIn:
”Platelets: 80,000/µL.
Chronic liver disease.
Aneurysmal intracranial bleed.
Multiple platelet transfusions already given.
The platelet count remained low.
But should we keep transfusing just to correct the number?
Viscoelastic hemostatic assay gave us the functional picture:
- R: 6.5 min — normal clot initiation
- MA: 58.1 mm — preserved overall clot strength
- CFF-MA: 23.3 mm — adequate fibrin contribution
- LY30: 0 percent — no evidence of increased fibrinolysis
In CLD, thrombocytopenia may partly reflect hypersplenism and splenic sequestration.
Despite a platelet count of 80,000/µL, this patient’s functional clot strength was preserved.
Integrating TEG with the clinical picture helped us avoid another empiric platelet transfusion merely to chase a number.
Complex clinical scenarios remind us why functional assays matter.
Numbers tell us what is low.
Functional assays help tell us whether haemostasis is actually impaired.
Platelet count does not equal clot strength
In Patient Blood Management, sometimes better testing guides us not only what to transfuse — but when not to transfuse.”

Stay updated with Hemostasis Today.
-
Oct 9, 2026, 15:15Maha Othman: Uncovering the Consensus on TXA in TBI – Call for Collaboration on a Landmark Umbrella Review
-
Oct 9, 2026, 15:07Daniel D. Han: How Inhalation Product Exposure Impairs Cardiac and Platelet Recovery After MI
-
Oct 9, 2026, 14:58William Toole: How Ultrasound-Guided PRP Therapy Relieves Joint and Tendon Pain
-
Oct 9, 2026, 14:50Shayan Mohammadmoradi: In Corpus Christi for the 20th Midwest Platelet Conference
-
Oct 9, 2026, 14:37Tariq Tramboo: High Platelet Concentrate for Osteoarthritis Knee – Recent Meta-Analyses
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning
-
Oct 9, 2026, 14:07Chokri Ben Lamine: Pain After Allogeneic Stem Cell Transplantation in Sickle Cell Disease
-
Oct 9, 2026, 13:55Chandler Purser: AABB 2026 Focuses on Transfusion Safety and Audit-Driven Practice Improvement